Keyphrases
Multiple Myeloma
100%
Waldenström Macroglobulinemia
100%
Cell Trafficking
100%
Phosphatidylinositol 3-kinase Inhibitor
100%
Buparlisib
100%
Myeloma Cells
87%
Cell Survival
50%
Waldenström
50%
Cell Apoptosis
37%
Phosphoinositide 3-kinase (PI3K)
25%
Adhesion
25%
Cell Mobilization
25%
Tumor Progression
25%
Kinase Inhibition
25%
Human Mesenchymal Stem Cells (hMSCs)
25%
Cell-to-cell
12%
Cell Cycle Arrest
12%
Tumor Growth
12%
B-cell Malignancies
12%
Apoptosis Induction
12%
Cell Adhesion
12%
Pharmacological Inhibitors
12%
Chemotaxis
12%
Drug Resistance
12%
Phosphatidylinositol 3-kinase Pathway
12%
Induced Toxicity
12%
In Vitro Growth
12%
Cell Dissemination
12%
Tumor Drugs
12%
CXCR4 Expression
12%
SiRNA Silencing
12%
Phosphatidylinositol 3-kinase Signaling
12%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Phosphatidylinositol 3 Kinase Inhibitor
100%
Waldenstroem macroglobulinemia
100%
Buparlisib
100%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
100%
Tumor Growth
30%
Small Interfering RNA
10%
Phosphatidylinositol 3 Kinase
10%
Drug Resistance
10%
Immunology and Microbiology
Cell Migration
100%
Multiple Myeloma
100%
Macroglobulinemia
100%
Myeloma Cell
70%
Cell Survival
40%
Programmed Cell Death
40%
Drug Resistance
10%
B Cell
10%
Cell Cycle
10%
Cell Adhesion
10%
Chemotaxis
10%
Upregulation
10%
CXCR4
10%
Cell Cycle Arrest
10%
Cell Cycle Checkpoint
10%
In Vitro
10%